Average Co-Inventor Count = 7.89
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (29 from 3,685 patents)
2. Bristol Meyers Squibb Company (1 from 41 patents)
3. Viiv Healthcare UK (no. 4) Limited (1 from 8 patents)
4. Viiv Healthcare UK Limited (9 patents)
31 patents:
1. 11369624 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents
2. 8871771 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents
3. 8461333 - Salts of prodrugs of piperazine and substituted piperidine antiviral agents
4. 8168615 - Prodrugs of piperazine and substituted piperidine antiviral agents
5. 8129398 - HIV integrase inhibitors
6. 8124615 - Diketo substituted pyrrolo[2,3-C]pyridines
7. 8039458 - HIV integrase inhibitors
8. 7960406 - Diketo substituted pyrrolo[2,3-c] pyridines
9. 7902182 - HIV integrase inhibitors
10. 7893055 - HIV integrase inhibitors
11. 7745625 - Prodrugs of piperazine and substituted piperidine antiviral agents
12. 7662823 - Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives
13. 7511037 - N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor
14. 7501420 - Composition and antiviral of substituted azaindoleoxoacetic piperazine derivatives
15. 7419969 - HIV integrase inhibitors: cyclic pyrimidinone compounds